Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
Alignment Healthcare Inc (NASDAQ: ALHC) closed the day trading at $18.04 up 1.52% from the previous closing price of $17.77. In other words, the price has increased by $1.52 from its previous closing price. On the day, 2.28 million shares were traded. ALHC stock price reached its highest trading level at $18.14 during the session, while it also had its lowest trading level at $17.53.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Goldman on October 14, 2025, initiated with a Buy rating and assigned the stock a target price of $21.
On August 25, 2025, KeyBanc Capital Markets Upgraded its rating to Overweight which previously was Sector Weight but kept the price unchanged to $21.
Barclays Upgraded its Underweight to Equal Weight on July 31, 2025, while the target price for the stock was maintained at $13.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 28 ’25 when KONOWIECKI JOSEPH S sold 25,000 shares for $18.00 per share. The transaction valued at 450,000 led to the insider holds 1,085,973 shares of the business.
Joseph Konowiecki bought 25,000 shares of ALHC for $450,000 on Oct 28 ’25. On Oct 10 ’25, another insider, KAO JOHN E, who serves as the Chief Executive Officer of the company, sold 180,000 shares for $17.29 each. As a result, the insider received 3,111,480 and left with 2,706,726 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALHC now has a Market Capitalization of 3572487168 and an Enterprise Value of 3398365696. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.07 while its Price-to-Book (P/B) ratio in mrq is 25.33. Its current Enterprise Value per Revenue stands at 1.019 whereas that against EBITDA is 432.032.
Stock Price History:
The Beta on a monthly basis for ALHC is 1.18, which has changed by 0.51491904 over the last 52 weeks, in comparison to a change of 0.18258524 over the same period for the S&P500. Over the past 52 weeks, ALHC has reached a high of $21.06, while it has fallen to a 52-week low of $10.18. The 50-Day Moving Average of the stock is 7.75%, while the 200-Day Moving Average is calculated to be 15.76%.
Shares Statistics:
Over the past 3-months, ALHC traded about 3.57M shares per day on average, while over the past 10 days, ALHC traded about 1845060 shares per day. A total of 197.96M shares are outstanding, with a floating share count of 157.63M. Insiders hold about 20.40% of the company’s shares, while institutions hold 80.61% stake in the company. Shares short for ALHC as of 1760486400 were 13661380 with a Short Ratio of 3.83, compared to 1757894400 on 12854317. Therefore, it implies a Short% of Shares Outstanding of 13661380 and a Short% of Float of 10.6300004.
Earnings Estimates
At present, 4.0 analysts are actively evaluating the performance of Alignment Healthcare Inc (ALHC) in the stock market.The consensus estimate for the next quarter is -$0.05, with high estimates of -$0.05 and low estimates of -$0.06.
Analysts are recommending an EPS of between $0.18 and $0.11 for the fiscal current year, implying an average EPS of $0.15. EPS for the following year is $0.32, with 4.0 analysts recommending between $0.4 and $0.26.
Revenue Estimates
11 analysts predict $981.35M in revenue for. The current quarter. It ranges from a high estimate of $985.9M to a low estimate of $978M. As of. The current estimate, Alignment Healthcare Inc’s year-ago sales were $692.43MFor the next quarter, 11 analysts are estimating revenue of $978.06M. There is a high estimate of $984.01M for the next quarter, whereas the lowest estimate is $968M.
A total of 11 analysts have provided revenue estimates for ALHC’s current fiscal year. The highest revenue estimate was $3.91B, while the lowest revenue estimate was $3.89B, resulting in an average revenue estimate of $3.9B. In the same quarter a year ago, actual revenue was $2.7BBased on 11 analysts’ estimates, the company’s revenue will be $4.96B in the next fiscal year. The high estimate is $5.47B and the low estimate is $4.77B.
